Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies
, oraz
04 lis 2020
O artykule
Data publikacji: 04 lis 2020
Zakres stron: 163 - 174
Przyjęty: 02 cze 2020
DOI: https://doi.org/10.2478/acph-2021-0016
Słowa kluczowe
© 2021 Safa Daoud et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Daoud, Safa
Department of Pharmaceutical, Chemistry and Pharmacognosy, Faculty of Pharmacy, Applied Science, Private UniversityAmman, Jordan
Alabed, Shada J.
Department of Pharmaceutical Sciences, School of Pharmacy, The University of JordanAmman, Jordan
Dahabiyeh, Lina A.
Department of Pharmaceutical Sciences, School of Pharmacy, The University of JordanAmman, Jordan